Performance evaluation of a rapid molecular diagnostic, MultiCode based, sample-to-answer assay for the simultaneous detection of Influenza A, B and respiratory syncytial viruses-Reference-Cited by-同舟云学术

Performance evaluation of a rapid molecular diagnostic, MultiCode based, sample-to-answer assay for the simultaneous detection of Influenza A, B and respiratory syncytial viruses

Published:2016-12 Issue: Volume:85 Page:65-70
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Voermans Jolanda J.C.,Seven-Deniz S.,Fraaij P.L.A.,van der Eijk Annemiek A.,Koopmans M.P.G.,Pas Suzan D.

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference20 articles.

1. A national study of the impact of rapid influenza testing on clinical care in the emergency department;Blaschke;J. Pediatr. Infect. Dis. Soc.,2014

2. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus;Madge;Lancet,1992

3. Effect of a rapid influenza diagnosis;Esposito;Arch. Dis. Child.,2003

4. Nucleic acid analysis using an expanded genetic alphabet to quench fluorescence;Sherrill;J. Am. Chem. Soc.,2004

5. A third base pair for the polymerase chain reaction: inserting isoC and isoG;Johnson;Nucleic Acids Res.,2004

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era;The Journal of Applied Laboratory Medicine;2022-07-20

2. Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials;Journal of Clinical Epidemiology;2022-07

3. Diagnostic Accuracy of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 Era;2022-02-15

4. Different Methods for Molecular and Rapid Detection of Human Novel Coronavirus;Current Pharmaceutical Design;2021-09-15

5. Point of care testing for infectious disease: ownership and quality;Journal of Antimicrobial Chemotherapy;2021-09-01